Clinical trials
Completed Obesity trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 3 |
| Amgen | 2 |
| Chinese University of Hong Kong | 2 |
| Novo Nordisk A/S | 2 |
| The Hong Kong Polytechnic University | 2 |
| Boehringer Ingelheim | 1 |
| Galmed Research and Development, Ltd. | 1 |
| Northwestern University | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 15 |
| Overweight | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Obesity, Abdominal | 2 |
| Weight Loss | 2 |
| Dermatitis, Atopic | 1 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Fatty Liver | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.